Technologies
Title: | Dry Powder Inhalation of Particles Containing Anti-tuberculosis Drugs |
Area: | Medical Sciences |
Focus Area: | Treatment of Pulmonary TB |
Patent: | ZA200603256 |
Social Benefits: | It is safe and helps is reducing drug intake over time thereby reducing duration of treatment. |
Developing Agency: | CSIR-Central Drug Research Institute (CDRI), Uttar Pradesh |
Technology Readiness Index: | Technology Demonstration |
Email: | director@cdri.res.in |
| Website Link : | http://www.cdri.res.in |
| Source (more info) : | https://t.ly/l_sb |
Brief Description
Description : | Treatment of pulmonary TB with orally-administered drugs is sub-optimal-exposing non-target tissues to toxic drugs and requiring large doses to build up effective concentrations in lungs . Prolonged dosing is required to build up and maintain effective concentrations in lungs . Patients remain infectious for considerable periods after initiating drug treatment. |